Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Duke-NUS Medical School Scientists Discover DEAF1 Protein Mechanism as Key to Reversing Muscle Loss in Sarcopenia and Cancer Cachexia
Stem Cell & Regenerative Medicine

Duke-NUS Medical School Scientists Discover DEAF1 Protein Mechanism as Key to Reversing Muscle Loss in Sarcopenia and Cancer Cachexia

Dwi Wanna Mar 24, 2026 0

As the global population undergoes a profound demographic shift toward an older age profile, the prevalence of age-related physical decline…

Read More
Stem Cell & Regenerative Medicine

MIT Engineers Reveal How Muscle Exercise Directly Stimulates Nerve Growth Through Biochemical and Physical Mechanisms

Dwi Wanna Mar 24, 2026 0

In a landmark study that bridges the gap between mechanical engineering and regenerative medicine, researchers at the Massachusetts Institute of…

Read More
Stem Cell & Regenerative Medicine

Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Weight Management and Aging

Dwi Wanna Mar 22, 2026 0

The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine, offering unprecedented efficacy in…

Read More

Posts pagination

1 … 3 4
The UK Must Supercharge Its Commercial Strategy to Boost Global Life Sciences CompetitivenessWHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.Project Hail Mary: A Scientific Scrutiny of Andy Weir’s Interstellar Rescue MissionGenome’s Early 3D Architecture Revealed: Challenging Decades of Biological Dogma
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ